Sign in
4

Changes in Ownership

Prelude Therapeutics Inc Filed Acc 0001562180-23-004479

Chief Legal Officer, Corp Sec. bought 2,400 shares at $5.39 ($12,936)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Lim Bryant David Chief Legal Officer, Corp Sec. 2023-05-24 Purchase +2,400 $5.39 $12,936 2,400 D
Open-market purchases · 2,400 sh · avg $5.39 · $12,936
Loading xslF345X04/primarydocument.xml…